NeuralPort

HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors at sub-cellular levels.In December 2022, HistoSonics Inc announced raised $85 million in a financing led by Johnson & Johnson Innovation with participation from existing investors including Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, among others

Kestra Medical Technologies是一家用于医疗保健行业的外部和内部心脏医疗设备的制造商。该公司的可穿戴式心律转复除颤器与设备疗法结合了技术方面，提供护理和重要信息，帮助患者及其护理团队和谐地监测、管理和保护生命。

在Raydiant Oximetry，我们开发了一种更好的胎儿监护仪，以改善分娩时母亲和婴儿的预后。